查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1503423

到 2030 年预填充式注射器包装市场预测：按类型、材料类型、分销管道、应用、最终用户和地区进行的全球分析

Prefilled Syringe Packaging Market Forecasts to 2030 - Global Analysis By Type (Single-Chamber, Dual-Chamber, Customized and Other Types), Material Type, Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球预预填充式注射器包装市场在预测期内将以 14.2% 的复合年增长率成长。

预填充式注射器包装是一种专用的容器，旨在储存和保护注射器内的疫苗和药物等药品，以供给药。这些容器经过精心设计，可保持无菌，确保剂量准确，并保护内容物在使用前免受污染和损坏。包装通常具有防篡改密封、无菌屏障和人体工学设计等功能，有助于在临床环境中轻鬆操作和安全注射，从而提高医疗保健服务的便利性和安全性，并提高效率。

慢性病增加

慢性病的增加也是市场扩张的一个主要因素。随着糖尿病、类风湿性关节炎和各种自体免疫疾病在全球范围内的盛行率增加，对高效药物传输系统的需求不断增加。预填充式注射器具有方便、剂量准确和降低污染风险等优点，越来越受到医疗保健提供者和患者的青睐。这一趋势证实了市场正在快速成长和发展，以有效应对医疗保健挑战。

严格的监管要求

由于严格的监管要求，市场面临重大挑战。遵守各种安全和品质标准，包括卫生当局製定的标准，需要在製造、标籤和分销过程中仔细注意细节。公司必须在研究、测试和文件方面投入大量资金，以确保其产品符合监管期望，这可能会延长交付时间并增加成本。遵守这些法规对于获得市场核准和维持患者对预填充式注射器产品安全性和有效性的信心至关重要。

扩大自行注射装置的采用

市面上自动注射器的采用率显着增加。这一趋势的推动因素是为治疗糖尿病和类风湿性关节炎等慢性病的患者提供便利和控制。自动注射器可以在家中轻鬆、准确地进行药物管理，减少医疗就诊次数并提高病患的自主权。这一转变代表了医疗保健服务的变革性演变，以回应患者对自我护理和个人化治疗选择日益增长的偏好。

高成本

市场面临重大成本挑战。特殊材料、严格的法规要求和复杂的组装流程等因素推高了製造成本。此外，确保无菌性和与各种药物的相容性也会增加成本。这些成本进一步受到对提高安全性和易用性的创新技术的需求的影响。公司不断寻求提高效率，降低成本，同时维持产品品质和法规遵循。

COVID-19 的影响：

COVID-19 大流行对预填充式注射器包装市场产生了重大影响，全球疫苗生产和分销工作推动了需求的增加。製造商面临着满足日益增长的生产要求、同时确保供应链弹性和法规遵循的挑战。包装材料和灭菌技术的创新也已出现，以提高安全性和效率。儘管最初受到干扰，但随着医疗保健系统优先考虑疫苗宣传活动，市场不断增长，凸显了预填充式注射器在大流行应对和未来医疗保健策略中的关键作用。

预计疫苗产业在预测期内将是最大的产业。

由于易于管理、污染风险降低和剂量准确等优点，疫苗预计将在预测期内成为最大的市场。这种包装形式也提高了疫苗的分发效率，特别是在偏远和资源有限的地区。预填充式注射器的趋势是由医疗保健专业人员对即用型解决方案的偏好所推动的，这些解决方案可以简化疫苗接种流程并提高患者的依从性。

预计医院业在预测期内复合年增长率最高。

预计医院业在预测期内复合年增长率最高。预填充式注射器可提高效率、简化药物管理并最大限度地减少医疗机构的废弃物。此外，预填充式注射器是首选，因为它们有助于感染控制通讯协定并且可以在紧急情况下立即使用。随着医院优先考虑以患者为中心的护理和业务效率，对预填充式注射器包装的需求持续稳定成长。

比最大的地区

由于对即用型给药系统的需求不断增长，预计北美在预测期内将占据最大的市场占有率。关键因素包括生物技术的进步、慢性病盛行率的上升以及向自我给药的转变。促进安全性和便利性的监管措施进一步支持市场扩张。该地区竞争格局的特点是主要企业专注于包装解决方案的创新和永续性，预计将持续成长。

复合年增长率最高的地区：

预计亚太地区在预测期内将维持最高的复合年增长率。随着日本和韩国等国家人口持续老化，对需要使用预填充式注射器进行注射治疗的慢性病治疗的需求不断增加。该地区的监管机构越来越多地核准预填充式注射器用于更广泛的药物配方，从而扩大了市场机会。预填充式注射器材料和设计的创新，包括提高针头安全性和药物稳定性，正在推动市场成长。

提供免费客製化：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球预填充式注射器包装市场：按类型

  • 单室
  • 双腔室
  • 客製化
  • 其他类型

第六章全球预填充式注射器包装市场：依材料类型

  • 塑胶
    • 聚丙烯
    • 环烯烃共聚物（COC）
    • 环烯烃聚合物（COP）
  • 玻璃

第七章全球预填充式注射器包装市场：依通路分类

  • 直销
  • 专业药房
  • 零售药房
  • 网路药房

第八章全球预填充式注射器包装市场：依应用分类

  • 疫苗
  • 单株抗体
  • 类风湿性关节炎
  • 过敏反应
  • 其他用途

第九章全球预填充式注射器包装市场：依最终用户分类

  • 日间手术中心 (ASC)
  • 居家照护环境
  • 医院
  • 诊所
  • 其他最终用户

第十章全球预填充式注射器包装市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第十一章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • Becton, Dickinson and Company（BD）
  • Gerresheimer
  • Schott AG
  • Nipro Corporation
  • AptarGroup, Inc.
  • SHL Group
  • Weigao Group
  • Haselmeier GmbH
  • Lonza Group
  • Zeon Corporation
  • Syntegon Technology GmbH
  • West Pharmaceutical Services, Inc.
  • ROVI Contract Manufacturing
  • Catalent, Inc.
  • Terumo Corporation
  • Topas Advanced Polymers GmbH
Product Code: SMRC26593

According to Stratistics MRC, the Global Prefilled Syringe Packaging Market is growing at a CAGR of 14.2% during the forecast period. Prefilled syringe packaging is the specialized containers designed to store and protect pharmaceutical products, such as vaccines or medications, within a syringe ready for administration. These containers are meticulously engineered to maintain sterility, ensure accurate dosage delivery, and safeguard the contents from contamination or damage until use. The packaging typically includes features like tamper-evident seals, sterile barriers, and ergonomic designs that facilitate easy handling and safe injection practices in clinical settings, thereby enhancing convenience, safety, and efficiency in healthcare delivery.

Market Dynamics:

Driver:

Rising prevalence of chronic diseases

The rising prevalence of chronic diseases is a key driver in the expansion of the market. As the incidence of conditions such as diabetes, rheumatoid arthritis, and various autoimmune diseases increases globally, there is a growing demand for efficient drug delivery systems. Prefilled syringes offer advantages in terms of convenience, accuracy of dosage, and reduced risk of contamination, making them increasingly favored by healthcare providers and patients alike. This trend underscores the market's rapid growth and evolution towards meeting healthcare challenges effectively.

Restraint:

Stringent regulatory requirements

The market faces significant challenges due to stringent regulatory requirements. Compliance with various safety and quality standards, including those set by health authorities demands meticulous attention to detail in manufacturing, labeling, and distribution processes. Companies must invest heavily in research, testing, and documentation to ensure products meet regulatory expectations, which can lead to extended timelines and increased costs. Adherence to these regulations is crucial for gaining market approval and maintaining patient trust in the safety and efficacy of prefilled syringe products.

Opportunity:

Growing adoption of self-injection devices

The market is experiencing a significant rise in self-injection device adoption. This trend is driven by the convenience and control it offers to patients managing chronic conditions such as diabetes and rheumatoid arthritis. Self-injection devices enable easy and accurate administration of medication at home, reducing healthcare visits and enhancing patient autonomy. This shift marks a transformative evolution in healthcare delivery, catering to the growing preference for self-care and personalized treatment options among patients globally.

Threat:

High cost

The market faces significant cost challenges. Factors such as specialized materials, stringent regulatory requirements, and complex assembly processes contribute to high production costs. Additionally, ensuring sterility and compatibility with various drugs adds to expenses. These costs are further impacted by the need for innovative technologies to improve safety and usability. Companies are continually seeking efficiencies to mitigate costs while maintaining product quality and regulatory compliance.

Covid-19 Impact:

The COVID-19 pandemic significantly impacted the Prefilled Syringe Packaging market, driving increased demand due to vaccine production and distribution efforts worldwide. Manufacturers faced challenges in meeting heightened production requirements while ensuring supply chain resilience and regulatory compliance. Innovations in packaging materials and sterilization techniques also emerged to enhance safety and efficiency. Despite initial disruptions, the market experienced growth as healthcare systems prioritized vaccination campaigns, highlighting the critical role of prefilled syringes in pandemic response and future healthcare strategies.

The vaccines segment is expected to be the largest during the forecast period

The vaccines is expected to be the largest during the forecast period due to advantages such as ease of administration, reduced risk of contamination, and precise dosing accuracy. This packaging format also enhances vaccine distribution efficiency, particularly in remote and resource-limited areas. The trend towards prefilled syringes is driven by healthcare professionals' preference for ready-to-use solutions, which streamline vaccination processes and improve patient compliance.

The hospitals segment is expected to have the highest CAGR during the forecast period

The hospitals segment is expected to have the highest CAGR during the forecast period. These attributes enhance efficiency in healthcare settings, streamline medication administration, and minimize waste. Additionally, prefilled syringes contribute to infection control protocols and are favored in emergency situations for their immediate usability. As hospitals prioritize patient-centric care and operational efficiency, the demand for prefilled syringe packaging continues to grow steadily.

Region with largest share:

North America is projected to hold the largest market share during the forecast period driven by increasing demand for ready-to-use drug delivery systems. Key factors include advancements in biotechnology, rising prevalence of chronic diseases and a shift towards self-administration of drugs. Regulatory initiatives promoting safety and convenience further propel market expansion. The region's competitive landscape features prominent players focusing on innovation and sustainability in packaging solutions, anticipating continued growth.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period. The aging population in countries like Japan and South Korea is boosting the demand for chronic disease treatments, which often require injectable therapies delivered via prefilled syringes. Regulatory agencies in the region are increasingly approving prefilled syringes for a wider range of drug formulations, which expands the market opportunities. Innovations in prefilled syringe materials and designs, including advancements in needle safety and drug stability, are driving market growth.

Key players in the market

Some of the key players in Prefilled Syringe Packaging market include Becton, Dickinson and Company (BD), Gerresheimer, Schott AG, Nipro Corporation, AptarGroup, Inc., SHL Group, Weigao Group, Haselmeier GmbH, Lonza Group, Zeon Corporation, Syntegon Technology GmbH, West Pharmaceutical Services, Inc. , ROVI Contract Manufacturing, Catalent, Inc., Terumo Corporation and Topas Advanced Polymers GmbH.

Key Developments:

In March 2024, SCHOTT Pharma expanded in the U.S. with New Prefillable Syringe Manufacturing Facility in Wilson, North Carolina. The new site will expand the U.S. supply chain for in-demand syringes that deliver lifesaving injectable medicines, vaccines, and other fields of applications, allowing SCHOTT Pharma to triple its contribution of glass and polymer syringes to the U.S. market by 2030.

In March 2023, SCHOTT launched production of amber pharma glass in India to meet increasing demand. Strategic move increases availability of borosilicate glass variations to manufacturers of pharma packaging in India and Asia

Types Covered:

  • Single-Chamber
  • Dual-Chamber
  • Customized
  • Other Types

Material Types Covered:

  • Plastic
  • Glass

Distribution Channels Covered:

  • Direct Sales
  • Specialty Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Applications Covered:

  • Vaccines
  • Monoclonal Antibodies
  • Rheumatoid Arthritis
  • Anaphylaxis
  • Other Applications

End Users Covered:

  • Ambulatory Surgical Centers (ASCs)
  • Home Care Settings
  • Hospitals
  • Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Prefilled Syringe Packaging Market, By Type

  • 5.1 Introduction
  • 5.2 Single-Chamber
  • 5.3 Dual-Chamber
  • 5.4 Customized
  • 5.5 Other Types

6 Global Prefilled Syringe Packaging Market, By Material Type

  • 6.1 Introduction
  • 6.2 Plastic
    • 6.2.1 Polypropylene
    • 6.2.2 Cyclic Olefin Copolymer (COC)
    • 6.2.3 Cyclic Olefin Polymer (COP)
  • 6.3 Glass

7 Global Prefilled Syringe Packaging Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Direct Sales
  • 7.3 Specialty Pharmacies
  • 7.4 Retail Pharmacies
  • 7.5 Online Pharmacies

8 Global Prefilled Syringe Packaging Market, By Application

  • 8.1 Introduction
  • 8.2 Vaccines
  • 8.3 Monoclonal Antibodies
  • 8.4 Rheumatoid Arthritis
  • 8.5 Anaphylaxis
  • 8.6 Other Applications

9 Global Prefilled Syringe Packaging Market, By End User

  • 9.1 Introduction
  • 9.2 Ambulatory Surgical Centers (ASCs)
  • 9.3 Home Care Settings
  • 9.4 Hospitals
  • 9.5 Clinics
  • 9.6 Other End Users

10 Global Prefilled Syringe Packaging Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Becton, Dickinson and Company (BD)
  • 12.2 Gerresheimer
  • 12.3 Schott AG
  • 12.4 Nipro Corporation
  • 12.5 AptarGroup, Inc.
  • 12.6 SHL Group
  • 12.7 Weigao Group
  • 12.8 Haselmeier GmbH
  • 12.9 Lonza Group
  • 12.10 Zeon Corporation
  • 12.11 Syntegon Technology GmbH
  • 12.12 West Pharmaceutical Services, Inc.
  • 12.13 ROVI Contract Manufacturing
  • 12.14 Catalent, Inc.
  • 12.15 Terumo Corporation
  • 12.16 Topas Advanced Polymers GmbH

List of Tables

  • Table 1 Global Prefilled Syringe Packaging Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Prefilled Syringe Packaging Market Outlook, By Type (2022-2030) ($MN)
  • Table 3 Global Prefilled Syringe Packaging Market Outlook, By Single-Chamber (2022-2030) ($MN)
  • Table 4 Global Prefilled Syringe Packaging Market Outlook, By Dual-Chamber (2022-2030) ($MN)
  • Table 5 Global Prefilled Syringe Packaging Market Outlook, By Customized (2022-2030) ($MN)
  • Table 6 Global Prefilled Syringe Packaging Market Outlook, By Other Types (2022-2030) ($MN)
  • Table 7 Global Prefilled Syringe Packaging Market Outlook, By Material Type (2022-2030) ($MN)
  • Table 8 Global Prefilled Syringe Packaging Market Outlook, By Plastic (2022-2030) ($MN)
  • Table 9 Global Prefilled Syringe Packaging Market Outlook, By Polypropylene (2022-2030) ($MN)
  • Table 10 Global Prefilled Syringe Packaging Market Outlook, By Cyclic Olefin Copolymer (COC) (2022-2030) ($MN)
  • Table 11 Global Prefilled Syringe Packaging Market Outlook, By Cyclic Olefin Polymer (COP) (2022-2030) ($MN)
  • Table 12 Global Prefilled Syringe Packaging Market Outlook, By Glass (2022-2030) ($MN)
  • Table 13 Global Prefilled Syringe Packaging Market Outlook, By Distribution Channel (2022-2030) ($MN)
  • Table 14 Global Prefilled Syringe Packaging Market Outlook, By Direct Sales (2022-2030) ($MN)
  • Table 15 Global Prefilled Syringe Packaging Market Outlook, By Specialty Pharmacies (2022-2030) ($MN)
  • Table 16 Global Prefilled Syringe Packaging Market Outlook, By Retail Pharmacies (2022-2030) ($MN)
  • Table 17 Global Prefilled Syringe Packaging Market Outlook, By Online Pharmacies (2022-2030) ($MN)
  • Table 18 Global Prefilled Syringe Packaging Market Outlook, By Application (2022-2030) ($MN)
  • Table 19 Global Prefilled Syringe Packaging Market Outlook, By Vaccines (2022-2030) ($MN)
  • Table 20 Global Prefilled Syringe Packaging Market Outlook, By Monoclonal Antibodies (2022-2030) ($MN)
  • Table 21 Global Prefilled Syringe Packaging Market Outlook, By Rheumatoid Arthritis (2022-2030) ($MN)
  • Table 22 Global Prefilled Syringe Packaging Market Outlook, By Anaphylaxis (2022-2030) ($MN)
  • Table 23 Global Prefilled Syringe Packaging Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 24 Global Prefilled Syringe Packaging Market Outlook, By End User (2022-2030) ($MN)
  • Table 25 Global Prefilled Syringe Packaging Market Outlook, By Ambulatory Surgical Centers (ASCs) (2022-2030) ($MN)
  • Table 26 Global Prefilled Syringe Packaging Market Outlook, By Home Care Settings (2022-2030) ($MN)
  • Table 27 Global Prefilled Syringe Packaging Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 28 Global Prefilled Syringe Packaging Market Outlook, By Clinics (2022-2030) ($MN)
  • Table 29 Global Prefilled Syringe Packaging Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.